跳至主要内容
临床试验/ISRCTN14434966
ISRCTN14434966进行中(未招募)Unknown

A randomised controlled trial comparing the clinical and cost-effectiveness of lymph node removal in patients undergoing curative surgery for localised high-risk prostate cancer

Cardiff and Vale University Health Board0 个研究点目标入组 1,080 人开始时间: 2024年8月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
1,080

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Adults =18 years
  • 2. Biopsy-proven clinically localised high-risk PCa
  • 3. Local multi-disciplinary review identifying those cases thought be suitable for RP; with negative staging imaging (as per local standard of care)
  • 4. Able and willing to give informed consent to participate and to participate in study procedures

排除标准

  • 1. Hormone therapy within the 3 months prior to consent
  • 2. Previous radical treatment for PCa (radical treatment includes radical prostatectomy and/or radiotherapy and/or focal therapy [eg cryotherapy or HIFU])
  • 3. Unsuitable for surgical treatment
  • 4. People without capacity

研究者

相似试验